Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

A decision is expected in the fourth quarter of 2025.

Children and young adults living in states with the biggest drops in Medicaid coverage experienced more prescription ...

Cost is a barrier to care for chronic and rare diseases, so financial assistance is way to lower that barrier and help people ...

High costs and the novelty and complexity of new therapies such as gene therapy present social determinants of health and ...

In January 2023, the Brukinsa, a next-generation BTK inhibitor, received FDA approval for chronic lymphocytic leukemia (CLL).

A new study by JAMA Health Forum found that universal annual depression screening for young adults during primary care visits ...

Cigna Healthcare’s medical care ratio increased to 82.2% in the first quarter compared with 79.9% in the first quarter of ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

In mice with human Merkel cell carcinoma, pyrvinium pamoate significantly reduced tumor growth, potentially offering a new ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Giant Eagle also helped EmpiRx Health create a national pharmacy care network that was purpose-built for pharmacy and grocery ...